Literature DB >> 15276464

Network integration of the adrenergic system in cardiac hypertrophy.

Liza Barki-Harrington1, Cinzia Perrino, Howard A Rockman.   

Abstract

Adrenergic receptors play a pivotal role in regulating cardiac function in response to a constantly changing environment. Altered alpha and beta adrenergic receptor signaling in vivo is associated with cardiac hypertrophy and failure. This review focuses on the different roles of adrenergic receptors in regulating cardiac function under normal and pathological conditions. Understanding the signaling mechanisms of these receptors in the context of the heart is likely to provide a better therapeutic approach towards treatment of heart failure. Copryright 2004 European Society of Cardiology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276464     DOI: 10.1016/j.cardiores.2004.03.011

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  34 in total

Review 1.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

2.  A novel miniaturized multimodal bioreactor for continuous in situ assessment of bioartificial cardiac tissue during stimulation and maturation.

Authors:  George Kensah; Ina Gruh; Jörg Viering; Henning Schumann; Julia Dahlmann; Heiko Meyer; David Skvorc; Antonia Bär; Payam Akhyari; Alexander Heisterkamp; Axel Haverich; Ulrich Martin
Journal:  Tissue Eng Part C Methods       Date:  2011-01-14       Impact factor: 3.056

3.  Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy.

Authors:  Gipsy Majumdar; Robert J Rooney; I Maria Johnson; Rajendra Raghow
Journal:  Physiol Genomics       Date:  2011-09-27       Impact factor: 3.107

Review 4.  Mitogen-activated protein kinases in heart development and diseases.

Authors:  Yibin Wang
Journal:  Circulation       Date:  2007-09-18       Impact factor: 29.690

5.  A novel steroid-like compound F90927 exerting positive-inotropic effects in cardiac muscle.

Authors:  Christophe Pignier; Markus Keller; Bruno Vié; Bernard Vacher; Maurice Santelli; Ernst Niggli; Marcel Egger; Bruno Le Grand
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

6.  The cAMP binding protein Epac modulates Ca2+ sparks by a Ca2+/calmodulin kinase signalling pathway in rat cardiac myocytes.

Authors:  Laetitia Pereira; Mélanie Métrich; María Fernández-Velasco; Alexandre Lucas; Jérôme Leroy; Romain Perrier; Eric Morel; Rodolphe Fischmeister; Sylvain Richard; Jean-Pierre Bénitah; Frank Lezoualc'h; Ana María Gómez
Journal:  J Physiol       Date:  2007-06-28       Impact factor: 5.182

7.  A system for screening agonists targeting beta2-adrenoceptor from Chinese medicinal herbs.

Authors:  Hui Wang; Shi-you Li; Chuan-ke Zhao; Xin Zeng
Journal:  J Zhejiang Univ Sci B       Date:  2009-04       Impact factor: 3.066

Review 8.  Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks.

Authors:  Ares Pasipoularides
Journal:  J Cardiovasc Transl Res       Date:  2016-02-18       Impact factor: 4.132

9.  β-adrenergic receptor stimulation transactivates protease-activated receptor 1 via matrix metalloproteinase 13 in cardiac cells.

Authors:  Fabrice Jaffré; Alan E Friedman; Zhaoyang Hu; Nigel Mackman; Burns C Blaxall
Journal:  Circulation       Date:  2012-05-18       Impact factor: 29.690

10.  Mitochondrial fission is required for cardiomyocyte hypertrophy mediated by a Ca2+-calcineurin signaling pathway.

Authors:  Christian Pennanen; Valentina Parra; Camila López-Crisosto; Pablo E Morales; Andrea Del Campo; Tomás Gutierrez; Pablo Rivera-Mejías; Jovan Kuzmicic; Mario Chiong; Antonio Zorzano; Beverly A Rothermel; Sergio Lavandero
Journal:  J Cell Sci       Date:  2014-04-28       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.